VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85).
Mineur P, Ménard JF, Le Loët X, Bernard JF, Grosbois B, Pollet JP, Azais I, Laporte JP, Doyen C, De Gramont A, Wetterwald M, Euller-Ziegler L, Peny AM, Monconduit M, Michaux JL.
Mineur P, et al. Among authors: doyen c.
Br J Haematol. 1998 Nov;103(2):512-7. doi: 10.1046/j.1365-2141.1998.00997.x.
Br J Haematol. 1998.
PMID: 9827927
Free article.
Clinical Trial.